雷洛昔芬在中国上市了吗?好购买吗？

Raloxifene is a drug used to treat and prevent osteoporosis in postmenopausal women and also reduces the incidence of invasive breast cancer in high-risk women. The drug was developed by Eli Lilly and Company of the United States under the trade name Evista. It has been launched in China and has been included in the medical insurance catalog. This article will conduct a detailed analysis of raloxifene's marketing status, purchase channels, and medical insurance coverage in China to help readers fully understand the accessibility and usage precautions of this drug.

Is raloxifene on the market in China?

As an important selective estrogen receptor modulator (SERM), it has been approved for marketing in many countries and regions around the world. In China, the drug has also passed relevant approvals and officially entered the market.

Time to market and background

Raloxifene was approved by the US FDA in 1997 under the trade name Evista. With its widespread use around the world, China has also gradually introduced this drug, providing a new treatment option for postmenopausal female osteoporosis patients.

Domestic generic drugs

In addition to the original drugs, generic drugs of raloxifene have also appeared on the Chinese market. These generic drugs are similar in quality and efficacy to the original drugs, but at a relatively lower price, further improving the accessibility of the drugs.

The launch of raloxifene in China has brought more treatment options to patients, especially the emergence of generic drugs, making this drug affordable to more patients.

Is raloxifene easy to buy?

The purchasing channels for raloxifene in China are relatively diverse, and patients can obtain it through hospitals, pharmacies, and online platforms.

Purchase in hospitals and pharmacies

As a prescription drug, patients need to purchase raloxifene in hospitals or large chain pharmacies with a doctor’s prescription. There is a price difference between original drugs and generic drugs, and patients can choose the appropriate version according to their own economic conditions.

Online purchasing channels

Some regular online pharmacies also provide sales services for raloxifene. When patients choose to purchase online, they need to pay attention to the platform qualifications and drug sources to avoid purchasing fake and shoddy products.

The purchase channel for raloxifene is relatively convenient, but patients need to use it under the guidance of a doctor and choose formal channels to ensure the quality of the drug.

Is raloxifene included in the national medical insurance?

Raloxifene has been included in the Chinese medical insurance catalog, which greatly reduces the financial burden on patients.

Medical insurance reimbursement ratio

According to the medical insurance policy, the reimbursement ratio of raloxifene varies from region to region. Patients can consult the local medical insurance department to learn about the specific reimbursement policy and self-payment ratio before use.

Medical insurance coverage

Raloxifene covered by medical insurance includes the original drug and some generic drugs. When using the drug, patients should pay attention to whether the drug is in the medical insurance catalog in order to enjoy medical insurance reimbursement.

After the inclusion of raloxifene in medical insurance, it has significantly reduced the financial pressure on patients, allowing more patients who need this drug to benefit.